190 related articles for article (PubMed ID: 7927138)
1. An immunohistological study of post-transfusion graft-versus-host disease (GVHD).
Hojo H; Kainuma Y; Kunori T; Wachi E; Wakasa H
Fukushima J Med Sci; 1993 Dec; 39(2):77-87. PubMed ID: 7927138
[TBL] [Abstract][Full Text] [Related]
2. An autopsy report of graft-versus-host disease (GVHD) following blood transfusion.
Otori K; Masuda C; Wanibuchi H; Nakanishi A; Kawabata K; Ohashi H; Fukushima S
Osaka City Med J; 1999 Jun; 45(1):37-43. PubMed ID: 10723200
[TBL] [Abstract][Full Text] [Related]
3. Measurement of recipient-specific alloreactivity: is GVHD predictable?
Theobald M; Bunjes D; Nierle T; Arnold R; Heimpel H
Bone Marrow Transplant; 1993; 12 Suppl 3():S18-23. PubMed ID: 8124251
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological features in patients with hepatic graft-versus-host disease.
Chiba T; Yokosuka O; Goto S; Fukai K; Imazeki F; Kohno Y; Nishimura M; Saito Y; Saisho H
Hepatogastroenterology; 2005; 52(66):1849-53. PubMed ID: 16334791
[TBL] [Abstract][Full Text] [Related]
5. T cell immunity and graft-versus-host disease (GVHD).
Ichiki Y; Bowlus CL; Shimoda S; Ishibashi H; Vierling JM; Gershwin ME
Autoimmun Rev; 2006 Jan; 5(1):1-9. PubMed ID: 16338205
[TBL] [Abstract][Full Text] [Related]
6. Monitoring systemic donor lymphocyte macrochimerism to aid the diagnosis of graft-versus-host disease after liver transplantation.
Taylor AL; Gibbs P; Sudhindran S; Key T; Goodman RS; Morgan CH; Watson CJ; Delriviere L; Alexander GJ; Jamieson NV; Bradley JA; Taylor CJ
Transplantation; 2004 Feb; 77(3):441-6. PubMed ID: 14966423
[TBL] [Abstract][Full Text] [Related]
7. Transfusion-induced graft-versus-host disease after liver transplantation. Documentation using polymerase chain reaction with HLA-DR sequence-specific primers.
Wisecarver JL; Cattral MS; Langnas AN; Shaw BW; Fox IJ; Heffron TG; Rubocki RJ
Transplantation; 1994 Aug; 58(3):269-71. PubMed ID: 8053046
[TBL] [Abstract][Full Text] [Related]
8. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
9. Treatment of acute post-transfusion- graft-versus-host disease (GVHD) with intravenous human immunoglobulins: a case report.
Orlandi C; Frassetto A; Gnucci E; Lehmann JR; Neri R; Melandri D
J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):760-1. PubMed ID: 16836524
[No Abstract] [Full Text] [Related]
10. Transfusion-associated graft-versus-host disease.
Dwyre DM; Holland PV
Vox Sang; 2008 Aug; 95(2):85-93. PubMed ID: 18544121
[TBL] [Abstract][Full Text] [Related]
11. Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy.
Massumoto C; Benyunes MC; Sale G; Beauchamp M; York A; Thompson JA; Buckner CD; Fefer A
Bone Marrow Transplant; 1996 Mar; 17(3):351-6. PubMed ID: 8704686
[TBL] [Abstract][Full Text] [Related]
12. Activation-associated phenotype of CD3 T cells in acute graft-versus-host disease.
Paz Morante M; Briones J; Canto E; Sabzevari H; Martino R; Sierra J; Rodriguez-Sanchez JL; Vidal S
Clin Exp Immunol; 2006 Jul; 145(1):36-43. PubMed ID: 16792671
[TBL] [Abstract][Full Text] [Related]
13. Alloreactive CD4 T lymphocytes responsible for acute and chronic graft-versus-host disease are contained within the CD45RChigh but not the CD45RClow subset.
Xystrakis E; Bernard I; Dejean AS; Alsaati T; Druet P; Saoudi A
Eur J Immunol; 2004 Feb; 34(2):408-17. PubMed ID: 14768045
[TBL] [Abstract][Full Text] [Related]
14. Exanthema and enanthema in graft versus host disease (GVHD).
Suzuki M; Kikkawa Y; Hasegawa T; Kaneko F
Fukushima J Med Sci; 1993 Dec; 39(2):101-7. PubMed ID: 7927132
[TBL] [Abstract][Full Text] [Related]
15. Acute graft-versus-host disease after bone marrow transplantation with a single HLA-DPB1*1001 mismatch: involvement of different TCRBV subsets.
Gaschet J; Gallot G; Ibisch C; Lim A; Even J; Vivien R; Hallet MM; Milpied N; Vié H
Bone Marrow Transplant; 1998 Aug; 22(4):385-92. PubMed ID: 9722075
[TBL] [Abstract][Full Text] [Related]
16. Transfusion-associated graft-versus-host disease in immunocompetent patients: case series and review of the literature.
Agbaht K; Altintas ND; Topeli A; Gokoz O; Ozcebe O
Transfusion; 2007 Aug; 47(8):1405-11. PubMed ID: 17655584
[TBL] [Abstract][Full Text] [Related]
17. Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Sanchez J; Casaño J; Alvarez MA; Roman-Gomez J; Martin C; Martinez F; Gomez P; Serrano J; Herrera C; Torres A
Br J Haematol; 2004 Sep; 126(5):697-703. PubMed ID: 15327522
[TBL] [Abstract][Full Text] [Related]
18. [A case of graft-versus-host disease following irradiated fresh blood transfusion].
Mishima A; Takeuchi Y; Ueda N; Sato M; Terada J; Kamiya Y; Okubo T; Usami S; Kotani H; Suzuki Y
Kyobu Geka; 1991 Sep; 44(10):825-7. PubMed ID: 1920999
[TBL] [Abstract][Full Text] [Related]
19. Transfusion-associated graft-versus-host disease: an overview and two case reports.
Spector D
Oncol Nurs Forum; 1995; 22(1):97-101. PubMed ID: 7708528
[TBL] [Abstract][Full Text] [Related]
20. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
